Comparing immediate and delayed IUD insertion after cesarean delivery
Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion
This study is testing whether putting in an IUD right after a cesarean delivery is better for satisfaction and fewer problems compared to waiting six weeks to have it inserted.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | Female |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06023849 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness and patient satisfaction of immediate post-placental intrauterine contraceptive device (IUD) insertion with conventional insertion at six weeks postpartum. It will evaluate key outcomes such as patient satisfaction, expulsion rates, and complications associated with both methods. The study targets women aged 18-40 who have delivered via cesarean section and wish to use an IUD for contraception. Participants will be monitored for any adverse effects and overall satisfaction with the chosen method of insertion.
Who should consider this trial
Good fit: Ideal candidates are women aged 18-40 who have had a full-term cesarean delivery and wish to use an IUD for contraception.
Not a fit: Patients with allergies to copper, uterine abnormalities, or those desiring pregnancy within a year may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve contraceptive options and satisfaction for postpartum women, potentially reducing unintended pregnancies.
How similar studies have performed: Previous studies have shown promising results for immediate IUD insertion, suggesting that this approach may be beneficial, though this specific comparison is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 18-40years. * Full term pregnancies delivered by cesarean section. * Desire to have intrauterine contraceptive device (Cu T) as a contraceptive option. * Agree to participate in the study. Exclusion Criteria: * Allergy to copper. * Ante- or intra-partum hemorrhage. * Ruptured of membranes for more than 18 h prior to delivery or Chorioamnionitis. * Known uterine abnormalities e.g., Bicornuate/septate Uterus, uterine myoma. * History of ectopic pregnancy. * Desire for pregnancy within 1 year of delivery. * Intrapartum fever \>38 c. * Sever thrombocytopenia.
Where this trial is running
Assiut
- Faculty of Medicin — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Ahmed osman, M.B.B.Ch
- Email: AhmedOsman.2244@azhar.edu.eg
- Phone: 01145883770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.